[The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].
Results are reported of the treatment of 116 patients with a control group pulmonary tuberculosis. Patients of the main group (76 persons) received thymalin at the early stages of chemotherapy. Results were compared with a control group. It is shown that immunochemotherapy allows to increase the treatment efficacy earlier with a parallel restoration of cellular immunity indices.